Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085620 | SCV000283108 | likely benign | Bloom syndrome | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000352401 | SCV000336210 | uncertain significance | not provided | 2015-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000573154 | SCV000672911 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV001818552 | SCV002069510 | likely benign | not specified | 2018-11-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000573154 | SCV002531249 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-30 | criteria provided, single submitter | curation | |
Natera, |
RCV001085620 | SCV001460770 | likely benign | Bloom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |